首页|医药新型研发机构安全监管与服务模式研究

医药新型研发机构安全监管与服务模式研究

扫码查看
作为国家战略科技力量的重要组成部分,新型研发机构拥有灵活的管理运行体制机制,在推进产业技术创新和促进科技成果转化等方面具有强大活力.随着南京市建设具有全球影响力的创新名城、打造生物医药产业地标的相关部署出台,大量孵化器和新型研发机构应运而生.种类繁多的危险化学品、变更频繁的工艺路径和高流动性科研人员等特点为医药新型研发机构的安全管理带来了巨大挑战.以南京生物医药谷为例,文章在分析医药新型研发机构及其孵化企业安全管理现状的基础上,探讨新型研发机构的安全监管与服务模式,并提出相应的对策建议.
Research on Safety Supervision and Service Model of Novel Research and Development Institutions in Pharmaceutical
Novel research and development(R&D)institution is an important part of the national strategic science and technology forces.It has flexible models in management and operation,strong vitality in promoting industrial technology innovation and the transformation of scientific and technological achievements.With the arrangement of building an innovative city with global influence and a landmark of the biomedical industry in Nanjing,a large number of novel R&D institutions have emerged.Due to the multiple types of hazardous chemicals,the frequently changing process paths and the high turnover rate,it has brought great challenges to the safety management of novel R&D institutions.This study will take Nanjing biotech and pharmaceutical vally as an example,analyze the current situation of safety management of both novel R&D institutions and their newly-established firm,explore the safety supervision and service mode of them,and put forward corresponding countermeasures.

pharmaceuticalnovel research and development institutionslaboratorysafety servicesafety supervision

赵欣月

展开 >

南京生物医药谷建设发展有限公司,江苏 南京 210000

医药 新型研发机构 实验室 安全服务 安全监管

2024

化工管理
中国化工企业管理协会

化工管理

影响因子:0.336
ISSN:1008-4800
年,卷(期):2024.(4)
  • 12